Simopoulos A P
Center for Genetics, Nutrition and Health, Washington, DC 20009.
Am J Clin Nutr. 1991 Sep;54(3):438-63. doi: 10.1093/ajcn/54.3.438.
Several sources of information suggest that man evolved on a diet with a ratio of omega 6 to omega 3 fatty acids of approximately 1 whereas today this ratio is approximately 10:1 to 20-25:1, indicating that Western diets are deficient in omega 3 fatty acids compared with the diet on which humans evolved and their genetic patterns were established. Omega-3 fatty acids increase bleeding time; decrease platelet aggregation, blood viscosity, and fibrinogen; and increase erythrocyte deformability, thus decreasing the tendency to thrombus formation. In no clinical trial, including coronary artery graft surgery, has there been any evidence of increased blood loss due to ingestion of omega 3 fatty acids. Many studies show that the effects of omega 3 fatty acids on serum lipids depend on the type of patient and whether the amount of saturated fatty acids in the diet is held constant. In patients with hyperlipidemia, omega 3 fatty acids decrease low-density-lipoprotein (LDL) cholesterol if the saturated fatty acid content is decreased, otherwise there is a slight increase, but at high doses (32 g) they lower LDL cholesterol; furthermore, they consistently lower serum triglycerides in normal subjects and in patients with hypertriglyceridemia whereas the effect on high-density lipoprotein (HDL) varies from no effect to slight increases. The discrepancies between animal and human studies most likely are due to differences between animal and human metabolism. In clinical trials eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the form of fish oils along with antirheumatic drugs improve joint pain in patients with rheumatoid arthritis; have a beneficial effect in patients with ulcerative colitis; and in combination with drugs, improve the skin lesions, lower the hyperlipidemia from etretinates, and decrease the toxicity of cyclosporin in patients with psoriasis. In various animal models omega 3 fatty acids decrease the number and size of tumors and increase the time elapsed before appearance of tumors. Studies with nonhuman primates and human newborns indicate that DHA is essential for the normal functional development of the retina and brain, particularly in premature infants. Because omega 3 fatty acids are essential in growth and development throughout the life cycle, they should be included in the diets of all humans. Omega-3 and omega 6 fatty acids are not interconvertible in the human body and are important components of practically all cell membranes. Whereas cellular proteins are genetically determined, the polyunsaturated fatty acid (PUFA) composition of cell membranes is to a great extent dependent on the dietary intake.(ABSTRACT TRUNCATED AT 400 WORDS)
多个信息来源表明,人类在进化过程中所食用的饮食中,ω-6与ω-3脂肪酸的比例约为1,而如今这一比例约为10:1至20 - 25:1,这表明与人类进化及遗传模式形成时的饮食相比,西方饮食中ω-3脂肪酸缺乏。ω-3脂肪酸会延长出血时间;降低血小板聚集、血液粘度和纤维蛋白原;并增加红细胞变形能力,从而降低血栓形成的倾向。在包括冠状动脉搭桥手术在内的任何临床试验中,均未发现因摄入ω-3脂肪酸而导致失血增加的证据。许多研究表明,ω-3脂肪酸对血脂的影响取决于患者类型以及饮食中饱和脂肪酸的量是否保持恒定。在高脂血症患者中,如果饱和脂肪酸含量降低,ω-3脂肪酸会降低低密度脂蛋白(LDL)胆固醇,否则会略有升高,但高剂量(32克)时会降低LDL胆固醇;此外,它们能持续降低正常人和高甘油三酯血症患者的血清甘油三酯,而对高密度脂蛋白(HDL)的影响则从无影响到略有升高不等。动物研究和人体研究之间的差异很可能是由于动物和人类新陈代谢的不同。在临床试验中,鱼油形式的二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)与抗风湿药物一起可改善类风湿性关节炎患者的关节疼痛;对溃疡性结肠炎患者有有益作用;与药物联合使用,可改善银屑病患者的皮肤病变、降低维甲酸引起的高脂血症并降低环孢素的毒性。在各种动物模型中,ω-3脂肪酸可减少肿瘤的数量和大小,并延长肿瘤出现前的时间。对非人类灵长类动物和人类新生儿的研究表明,DHA对视网膜和大脑的正常功能发育至关重要,尤其是对早产儿。由于ω-3脂肪酸在整个生命周期的生长和发育中都必不可少,因此应纳入所有人的饮食中。ω-3和ω-6脂肪酸在人体内不能相互转化,并且几乎是所有细胞膜的重要组成部分。细胞蛋白质由基因决定,而细胞膜的多不饱和脂肪酸(PUFA)组成在很大程度上取决于饮食摄入。(摘要截取自400字)